Horizon Therapeutics Newswire (Page 8)

Comprehensive Real-Time News Feed for Horizon Therapeutics. (Page 8)

Results 141 - 160 of 837 in Horizon Therapeutics

  1. Medtronic acquisition almost doneRead the original story w/Photo

    Dec 1, 2014 | Business Journal

    The U.S. Federal Trade Commission and the European Commission have cleared the deal, which is worth an estimated $42.9 billion. Medtronic announced its plan to acquire Covidien in June .

    Comment?

  2. The Wall Street Journal: Medtronic selling at least $10 billion of bonds for Covidien acquisitionRead the original story w/Photo

    Dec 1, 2014 | MarketWatch

    Medical-device manufacturer Medtronic Inc. is expected to sell at least $10 billion of bonds Monday to help pay for its acquisition of Ireland's Covidien PLC, making it one of the largest bond deals of the year, according to investors familiar with the deal. Final prices and the size of the deal haven't been set, but the maturities of the debt are expected to range from three to 30 years.

    Comment?

  3. European Commission Clears Medtronic Acquisition of CovidienRead the original story

    Nov 28, 2014 | PressReleasePoint

    MINNEAPOLIS AND DUBLIN, Ireland - Nov. 28, 2014 - Medtronic, Inc. and Covidien plc today announced that the European Commission has conditionally cleared Medtronic's proposed acquisition of Covidien. The clearance decision is conditional on Medtronic's commitment to divest Covidien's drug coated balloon business.

    Comment?

  4. Medtronic Acquisition of Covidien Receives U.S. FTC ClearanceRead the original story

    Nov 26, 2014 | PressReleasePoint

    MINNEAPOLIS AND DUBLIN, Ireland - Nov. 26, 2014 - Medtronic, Inc. and Covidien plc today announced the receipt of U.S. Federal Trade Commission clearance of Medtronic's proposed acquisition of Covidien. "This regulatory clearance represents an important milestone in bringing our companies together," said Omar Ishrak, Chairman and CEO of Medtronic.

    Comment?

  5. FTC approves Medtronic acquisition of CovidienRead the original story w/Photo

    Nov 26, 2014 | NewsOK.com

    The U.S. Federal Trade Commission said Wednesday that it approved Medtronic's $42.9 billion acquisition of Covidien after the medical device maker agreed to sell a business that makes a type of catheter used in veins. Medtronic said it will sell Covidien's drug-coated balloon catheter business to Colorado Springs, Colorado-based The Spectranetics Corp. shortly after its acquisition of Covidien closes.

    Comment?

  6. Medtronic gets U.S. antitrust OK to buy Covidien with divestitureRead the original story

    Nov 26, 2014 | Vallejo News

    Medtronic Inc has won U.S. antitrust approval to buy Dublin-based Covidien Plc on condition that it sell its drug-coated balloon catheter business, the Federal Trade Commission said on Wednesday. Medtronic, a Minneapolis-based maker of defibrillators, spinal implants, insulin pumps and other products, said previously that it expected the transaction to close in early 2015.

    Comment?

  7. UPDATE 1-Medtronic gets U.S. antitrust OK to buy Covidien with divestitureRead the original story

    Nov 26, 2014 | Reuters

    Medtronic Inc has won U.S. antitrust approval to buy Dublin-based Covidien Plc on condition that it sell its drug-coated balloon catheter business, the Federal Trade Commission said on Wednesday. Medtronic, a Minneapolis-based maker of defibrillators, spinal implants, insulin pumps and other products, said previously that it expected the transaction to close in early 2015.

    Comment?

  8. Competition Bureau Reaches Consent Agreement in Medtronic/Covidien DealRead the original story

    Nov 26, 2014 | Sys-Con Media

    The Competition Bureau announced today that it has reached a consent agreement with Medtronic Inc. and Covidien plc that resolves the Bureau's concerns related to Medtronic's proposed acquisition of Covidien. Both companies sell medical devices in Canada for the treatment of various conditions.

    Comment?

  9. Dividend Aristocrats In Focus Part 44: MedtronicRead the original story w/Photo

    Nov 26, 2014 | Seeking Alpha

    Medtronic was founded in 1949. The company has grown into the largest publicly traded medical technology company with a market cap of $71 billion.

    Comment?

  10. Diabetes Innovation Progress: Walls Tumbling DownRead the original story w/Photo

    Nov 26, 2014 | Diabetes Mine

    Last Friday we held the 2014 DiabetesMine Innovation Summit , the fourth of these events we've done at the Stanford University School of Medicine - which exceed expectations, if we do say so ourselves This year's Summit was standing-room-only, attended by 135 passionate diabetes "stakeholders," ranging from players to payers. Present were key individuals from industry, finance, research, medical care, insurance, government, technology, and patient advocacy.

    Comment?

  11. Value-Based Healthcare As Seen By Medtronic's CEORead the original story w/Photo

    Nov 24, 2014 | Medical Device/Diagnostic Ind.

    In a wide-ranging interview at a Minneapolis conference, Medtronic's CEO describes what value-based healthcare is and why it is important. LIfeScience Alley CEO Shaye Mandle interviews Medtronic CEO Omar Ishrak at LifeScience Alley's annual conference in Minneapolis last week.

    Comment?

  12. CardiAQa Valve Technologies Names Jack Lips and Steven Marmon as...Read the original story

    Nov 24, 2014 | Freshnews

    CardiAQ Valve Technologies, Inc announced today that it has appointed Jack Lips as Clinical Specialist Manager and Steven Marmon as Clinical Trial Manager. In these positions, they are individually responsible for differing aspects of overseeing the current Compassionate Feasibility Study, as well as initiating and managing the definitive multinational CE Mark clinical trial for the purpose of seeking marketing approval in Europe of the Company's proprietary Trans-Femoral and Trans-Apical Systems for Transcatheter Mitral Valve Implantation .

    Comment?

  13. Jefferies Group Raises Medtronic Price Target to $83.00Read the original story w/Photo

    Nov 19, 2014 | AmericanBankingNews.com

    The firm currently has a "buy" rating on the stock. Jefferies Group's price target would suggest a potential upside of 14.53% from the stock's previous close.

    Comment?

  14. Provider, Payor Put Down "Boxing Gloves" to Improve CareRead the original story w/Photo

    Nov 19, 2014 | Medical Device/Diagnostic Ind.

    SharedClarity, a startup entity orginally formed by UnitedHealthcare and Dignity Health wants to change how hospitals source some of their most expensive products. SharedClarity, an early stage startup, wants to prove to the world that breaking the cycle of past animosity between payors and health providers might be mutually beneficial.

    Comment?

  15. Oppenheimer Raises Medtronic Price Target to $78.00Read the original story w/Photo

    Nov 19, 2014 | AmericanBankingNews.com

    The firm currently has an "outperform" rating on the stock. Oppenheimer's price objective suggests a potential upside of 7.63% from the company's current price.

    Comment?

  16. Pharmaceuticals give stock markets a boostRead the original story w/Photo

    Nov 18, 2014 | Salt Lake Tribune

    Stocks moved higher in late afternoon trading Tuesday, on track to deliver a record-high close for the Dow Jones industrial average and Standard & Poor's 500 index. Pharmaceutical and medical equipment stocks were among the biggest gainers.

    Comment?

  17. Medtronic plans to complete Covidien dealRead the original story w/Photo

    Nov 18, 2014 | USA Today

    Medical device giant Medtronic Tuesday reiterated its plan to buy Ireland-based rival Covidien in a deal expected to cut the Minneapolis-based company's future U.S. tax bills. Medtronic plans to complete Covidien deal Medical device giant Medtronic Tuesday reiterated its plan to buy Ireland-based rival Covidien in a deal expected to cut the Minneapolis-based company's future U.S. tax bills.

    Comment?

  18. Analysts like Medtronic moves, earningsRead the original story w/Photo

    Nov 18, 2014 | Business Journal

    A slight increase in spinal revenue, momentum from new products and progress in its acquisition of Covidien have analysts looking positively at Medtronic Inc. The company reported its fiscal second quarter earnings this morning, with sales of $4.3 billion, a five percent year-over-year increase. Medtronic Spine's revenue increased 1 percent to $746 million.

    Comment?

  19. US stocks get a boost from pharma companiesRead the original story w/Photo

    Nov 18, 2014 | Worcester Telegram & Gazette

    Stocks moved higher in late afternoon trading Tuesday, on track to deliver a record-high close for the Dow Jones industrial average and Standard & Poor's 500 index. Pharmaceutical and medical equipment stocks were among the biggest gainers.

    Comment?

  20. Medtronic sees flat spine revenueRead the original story w/Photo

    Nov 18, 2014 | Business Journal

    Despite flat revenue for its Memphis-based spinal division, Medtronic Inc. saw a 5 percent increase in its fiscal second quarter, while net income dropped. Medtronic reported sales of $4.3 billion for the fiscal second quarter of 2015, and earnings of $828 million, a decline from $902 million in the fiscal second quarter of 2014.

    Comment?